In the present study, we demonstrated that, at least in our cases, pituitary adenomas are EPOR negative tumors and systematic rhEPO administration may promote tumor growth of pituitary adenomans via enhancing angiogenesis though the EPO-JAK2-STAT3-VEGF signal pathway. Here, JAK2 is linked to neoplasm.